Analysis of the use of oral hypoglycemic drugs in a certain hospital under the background of national centralized procurement
Objective To explore the impact of the second,third,fourth,and fifth batches of national centralized volume-based procurement(hereinafter referred to as"national centralized procurement")on the use of oral hypoglycemic drugs in Quanzhou First Hospital(hereinafter referred to as"a hospital")after procurement implementation,and to provide optimization suggestions for hospital pharmaceutical management and clinical medication.Methods The usage data of oral hypoglycemic drugs in each batch of national centralized procurement in the information system of a certain hospital for one year before and after procurement implementation was collected,indicators such as unit price decreasing amplitude,defined daily dose system(DDDs),drug usage amount,defined daily dose cost(DDC),the proportion of similar drug usage,cost savings,and cost savings rate were counted,and the impact of national centralized procurement policies was analyzed.Results After the implementation of national centralized procurement,the prices of selected varieties in each batch showed varying degrees of reduction.The DDC and usage amount of most centralized procurement varieties significantly decreased,and their usage and DDDs increased year-on-year.The cost savings of drugs were 104,000 yuan to 2,844,900 yuan,with a cost savings rate of 18.79%to 4340.88%.However,some similar alternative varieties experienced an increase in DDDs after the implementation of centralized procurement.Conclusion After implementing national centralized procurement,the cost of oral hypoglycemic drugs in a certain hospital has significantly decreased,effectively reducing the burden of drug costs on patients.During the implementation of centralized procurement,a certain hospital still needs to optimize the management plan of centralized procurement drugs and similar alternative drugs to promote the further implementation of centralized procurement policies.